NCT05100082View on ClinicalTrials.gov

Survey of Cabozantinib Tablets Used To Treat People With Hepatocellular Carcinoma

Active, not recruitingOBSERVATIONAL

Enrollment

263

Participants

Timeline

Start Date

November 17, 2021

Primary Completion Date

November 30, 2025

Study Completion Date

November 30, 2025

Conditions

Hepatocellular Cancer

Interventions

DRUG

Cabozantinib

Cabozantinib tablets

Trial Locations (1)

Unknown

Takeda Selected Site, Tokyo

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Takeda

INDUSTRY